Nouveautés dans l’encéphalopathie hépatique : de l’encéphalopathie hépatique minimale à l’encéphalopathie hépatique clinique

Vilstrup, 2014, Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver, Hepatol Baltim Md, 60, 715, 10.1002/hep.27210 García-Pagán, 2010, Early use of TIPS in patients with cirrhosis and variceal bleeding, N Engl J Med, 362, 2370, 10.1056/NEJMoa0910102 Bureau, 2017, Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites, Gastroenterology, 152, 157, 10.1053/j.gastro.2016.09.016 Prasad, 2007, Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy, Hepatology, 45, 549, 10.1002/hep.21533 Patidar, 2014, Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization, Am J Gastroenterol, 109, 1757, 10.1038/ajg.2014.264 Bustamante, 1999, Prognostic significance of hepatic encephalopathy in patients with cirrhosis, J Hepatol, 30, 890, 10.1016/S0168-8278(99)80144-5 Weiss, 2017, Understanding hepatic encephalopathy, Intensive Care Med Clemmesen, 1999, Cerebral herniation in patients with acute E liver failure is correlated with arterial ammonia concentration, Hepatology, 29, 648, 10.1002/hep.510290309 Schliess, 2006, Pathogenetic interplay between osmotic and oxidative stress: the hepatic encephalopathy paradigm, Biol Chem, 387, 10.1515/BC.2006.171 Shawcross, 2011, Infection and systemic inflammation, not ammonia, are associated with grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis, J Hepatol, 54, 640, 10.1016/j.jhep.2010.07.045 Merli, 2013, Increased risk of cognitive impairment in cirrhotic patients with bacterial infections, J Hepatol, 59, 243, 10.1016/j.jhep.2013.03.012 Shawcross, 2004, Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis, J Hepatol, 40, 247, 10.1016/j.jhep.2003.10.016 Bajaj, 2012, Linkage of gut microbiome with cognition in hepatic encephalopathy, AJP Gastrointest Liver Physiol, 302, G168, 10.1152/ajpgi.00190.2011 Nguyen, 2006, Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure mice, J Hepatol, 44, 1105, 10.1016/j.jhep.2005.09.019 Weiss, 2016, Cerebrospinal fluid metabolomics highlights dysregulation of energy metabolism in overt hepatic encephalopathy, J Hepatol, 65, 1120, 10.1016/j.jhep.2016.07.046 Palomero-Gallagher, 2013, Neurotransmitter receptor alterations in hepatic encephalopathy: a review, Arch Biochem Biophys, 536, 109, 10.1016/j.abb.2013.02.010 Ferrara, 2009, Acquired hepatocerebral degeneration, J Neurol, 256, 320, 10.1007/s00415-009-0144-7 Bajaj, 2007, Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations, Am J Gastroenterol, 102, 1903, 10.1111/j.1572-0241.2007.01424.x Weissenborn, 2001, Neuropsychological characterization of hepatic encephalopathy, J Hepatol, 34, 768, 10.1016/S0168-8278(01)00026-5 Thabut, 2014, Diagnosis of minimal hepatic encephalopathy in patients with cirrhosis: Should we bury psychometric tests?, Hepatology, 59, 2428, 10.1002/hep.26967 Schomerus, 1999 Lauridsen, 2015, Minimal hepatic encephalopathy characterized by parallel use of the continuous reaction time and portosystemic encephalopathy tests, Metab Brain Dis, 30, 1187, 10.1007/s11011-015-9688-7 Bajaj, 2008, Inhibitory control test for the diagnosis of minimal hepatic encephalopathy, Gastroenterology, 135, 10.1053/j.gastro.2008.07.021 Corrias, 2014, Covert hepatic encephalopathy: does the mini-mental state examination help?, J Clin Exp Hepatol, 4, 89, 10.1016/j.jceh.2013.12.005 Kircheis, 2002, Critical flicker frequency for quantification of low-grade hepatic encephalopathy, Hepatology, 35, 357, 10.1053/jhep.2002.30957 Kircheis, 2014, Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy, Gastroenterology, 146, 10.1053/j.gastro.2013.12.026 Marchetti, 2011, Electroencephalography in patients with cirrhosis, Gastroenterology, 141, 10.1053/j.gastro.2011.06.085 Rudler, 2017, Status epilepticus in patients with cirrhosis: how to avoid misdiagnosis in patients with hepatic encephalopathy?, Seizure, 45, 192, 10.1016/j.seizure.2016.12.011 Amodio, 1999, Spectral versus visual EEG analysis in mild hepatic encephalopathy, Clin Neurophysiol, 110, 1334, 10.1016/S1388-2457(99)00076-0 Amodio, 2006, The EEG assessment of low-grade hepatic encephalopathy: comparison of an artificial neural network-expert system (ANNES) based evaluation with visual EEG readings and EEG spectral analysis, Clin Neurophysiol, 117, 2243, 10.1016/j.clinph.2006.06.714 Pujol, 1993, Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure, Neurology, 43, 65, 10.1212/WNL.43.1_Part_1.65 Fukuzawa, 2006, Magnetic resonance images of the globus pallidus in patients with idiopathic portal hypertension: a quantitative analysis of the relationship between signal intensity and the grade of portosystemic shunt, J Gastroenterol Hepatol, 21, 902, 10.1111/j.1440-1746.2006.04226.x Chavarria, 2015, Magnetic resonance imaging and spectroscopy in hepatic encephalopathy, J Clin Exp Hepatol, 5, S69, 10.1016/j.jceh.2013.10.001 Shawcross, 2004, Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia, AJP Gastrointest Liver Physiol, 287, G503, 10.1152/ajpgi.00104.2004 Montagnese, 2014, Covert hepatic encephalopathy: agreement and predictive validity of different indices, World J Gastroenterol, 20, 15756, 10.3748/wjg.v20.i42.15756 Poynard, 2011, First-line assessment of patients with chronic liver disease with non-invasive techniques and without recourse to liver biopsy, J Hepatol, 54, 586, 10.1016/j.jhep.2010.09.012 Tapper, 2017, Use of liver imaging and biopsy in clinical practice, N Engl J Med, 377, 756, 10.1056/NEJMra1610570 Córdoba, 2004, Normal protein diet for episodic hepatic encephalopathy: results of a randomized study, J Hepatol, 41, 38, 10.1016/j.jhep.2004.03.023 Als-Nielsen, 2004, Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials, BMJ, 328, 1046, 10.1136/bmj.38048.506134.EE Sharma, 2011, Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose: lactulose in acute variceal bleed, J Gastroenterol Hepatol, 26, 996, 10.1111/j.1440-1746.2010.06596.x Rahimi, 2014, Lactulose vs polyethylene glycol 3350--electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial, JAMA Intern Med, 174, 1727, 10.1001/jamainternmed.2014.4746 Bass, 2010, Rifaximin treatment in hepatic encephalopathy, N Engl J Med, 362, 1071, 10.1056/NEJMoa0907893 Mullen, 2014, Rifaximin is safe and well tolerated for long-term maintenance of remission from overt hepatic encephalopathy, Clin Gastroenterol Hepatol, 12, 10.1016/j.cgh.2013.12.021 Rockey, 2014, Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy, Hepatol Baltim Md, 59, 1073, 10.1002/hep.26611 Kao, 2016, Fecal microbiota transplantation in the management of hepatic encephalopathy, Hepatology, 63, 339, 10.1002/hep.28121 Bajaj, 2017, Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial, Hepatol Baltim Md, 10.1002/hep.29306 Goulenok, 2002, Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis, Aliment Pharmacol Ther, 16, 361, 10.1046/j.1365-2036.2002.01191.x